Libo Pharma Corp. (TPEX: 7888)
Health Care · Biotechnology · TW
NT$29.90
-0.33% today · -36.6% 1Y
Libo Pharma Corp. (TPEX: 7888) operates in the Biotechnology industry within the Health Care sector. The company is valued at $70.31M.
Over the last twelve months the share price has lost 36.6%, trading between 27.50 and 69.00.
Tweenvest scores Libo Pharma Corp. across four factors: quality 28/100. Its strongest factor is quality.
7888 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $70.31M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -4.74
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- NT$69.00
- 52-week low
- NT$27.50
- Avg volume (3M)
- —
- Shares outstanding
- 75.23M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $64.17B | €879.20 | +1.74% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $158.83 | +14.36% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.